SRX sierra rutile holdings limited
Add to My Watchlist 0.00% ! 17.5¢

Y90

  1. cafa
    8,918 Posts.
    lightbulb Created with Sketch. 32
    clock Created with Sketch.
    06/12/16
    22:18
    Post #: 21152489
    https://www.spandidos-publications.com/or/37/1/57
      


    'In conclusion, 90Y radioembolization is an effective treat-
    ment for CRCLM in extending local control for liver dominant
    metastatic disease. However, KRAS mutant tumors may be
    more radio-resistant to treatment. In this study, changes in
    ccfDNA FI were correlated with overall survival, likely indi-
    cating that these changes are reflective of treatment response.
    Measurements of FI may have the potential to be another
    molecular biomarker that could predict treatment response to
    therapy.'

    Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients:
    SRX Price at posting: $26.04 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.